649 related articles for article (PubMed ID: 7860733)
41. A novel cryptic exon identified in the 3' region of intron 2 of the human dystrophin gene.
Tran VK; Zhang Z; Yagi M; Nishiyama A; Habara Y; Takeshima Y; Matsuo M
J Hum Genet; 2005; 50(8):425-433. PubMed ID: 16133659
[TBL] [Abstract][Full Text] [Related]
42. Surveying cis-acting sequences of pre-mRNA by adding antisense 2'-O-methyl oligoribonucleotides to a splicing reaction.
Mayeda A; Hayase Y; Inoue H; Ohtsuka E; Ohshima Y
J Biochem; 1990 Sep; 108(3):399-405. PubMed ID: 2277033
[TBL] [Abstract][Full Text] [Related]
43. Deletion of a splice donor site ablates expression of the following exon and produces an unphosphorylated RB protein unable to bind SV40 T antigen.
Shew JY; Chen PL; Bookstein R; Lee EY; Lee WH
Cell Growth Differ; 1990 Jan; 1(1):17-25. PubMed ID: 1964074
[TBL] [Abstract][Full Text] [Related]
44. A non-conserved sequence in the 5'region of the CYH2 intron from Saccharomyces cerevisiae controls splicing efficiency of the pre-mRNA.
Swida U; Thüroff E; Steinert E; Käufer NF
Yeast; 1988 Sep; 4(3):209-17. PubMed ID: 3059718
[TBL] [Abstract][Full Text] [Related]
45. Self-splicing of the bacteriophage T4 group I introns requires efficient translation of the pre-mRNA in vivo and correlates with the growth state of the infected bacterium.
Sandegren L; Sjöberg BM
J Bacteriol; 2007 Feb; 189(3):980-90. PubMed ID: 17122344
[TBL] [Abstract][Full Text] [Related]
46. Antisense modulation of both exonic and intronic splicing motifs induces skipping of a DMD pseudo-exon responsible for x-linked dilated cardiomyopathy.
Rimessi P; Fabris M; Bovolenta M; Bassi E; Falzarano S; Gualandi F; Rapezzi C; Coccolo F; Perrone D; Medici A; Ferlini A
Hum Gene Ther; 2010 Sep; 21(9):1137-46. PubMed ID: 20486769
[TBL] [Abstract][Full Text] [Related]
47. Antisense oligonucleotide induced exon skipping and the dystrophin gene transcript: cocktails and chemistries.
Adams AM; Harding PL; Iversen PL; Coleman C; Fletcher S; Wilton SD
BMC Mol Biol; 2007 Jul; 8():57. PubMed ID: 17601349
[TBL] [Abstract][Full Text] [Related]
48. Heterogous dystrophin mRNA produced by a novel splice acceptor site mutation in intermediate dystrophinopathy.
Adachi K; Takeshima Y; Wada H; Yagi M; Nakamura H; Matsuo M
Pediatr Res; 2003 Jan; 53(1):125-31. PubMed ID: 12508091
[TBL] [Abstract][Full Text] [Related]
49. Alternative splicing of human dystrophin mRNA generates isoforms at the carboxy terminus.
Feener CA; Koenig M; Kunkel LM
Nature; 1989 Apr; 338(6215):509-11. PubMed ID: 2648158
[TBL] [Abstract][Full Text] [Related]
50. Exonic sequences provide better targets for antisense oligonucleotides than splice site sequences in the modulation of Duchenne muscular dystrophy splicing.
Aartsma-Rus A; Houlleberghs H; van Deutekom JC; van Ommen GJ; 't Hoen PA
Oligonucleotides; 2010 Apr; 20(2):69-77. PubMed ID: 20377429
[TBL] [Abstract][Full Text] [Related]
51. Contemporary retrotransposition of a novel non-coding gene induces exon-skipping in dystrophin mRNA.
Awano H; Malueka RG; Yagi M; Okizuka Y; Takeshima Y; Matsuo M
J Hum Genet; 2010 Dec; 55(12):785-90. PubMed ID: 20827276
[TBL] [Abstract][Full Text] [Related]
52. Upstream introns influence the efficiency of final intron removal and RNA 3'-end formation.
Nesic D; Maquat LE
Genes Dev; 1994 Feb; 8(3):363-75. PubMed ID: 7906237
[TBL] [Abstract][Full Text] [Related]
53. Neuronal SH-SY5Y cells use the C-dystrophin promoter coupled with exon 78 skipping and display multiple patterns of alternative splicing including two intronic insertion events.
Nishida A; Minegishi M; Takeuchi A; Awano H; Niba ET; Matsuo M
Hum Genet; 2015 Sep; 134(9):993-1001. PubMed ID: 26152642
[TBL] [Abstract][Full Text] [Related]
54. A new variant of muscle phosphofructokinase deficiency in a Japanese case with abnormal RNA splicing.
Hamaguchi T; Nakajima H; Noguchi T; Ono A; Kono N; Tarui S; Kuwajima M; Matsuzawa Y
Biochem Biophys Res Commun; 1994 Jul; 202(1):444-9. PubMed ID: 7518679
[TBL] [Abstract][Full Text] [Related]
55. The role of exon sequences in splice site selection.
Watakabe A; Tanaka K; Shimura Y
Genes Dev; 1993 Mar; 7(3):407-18. PubMed ID: 8449402
[TBL] [Abstract][Full Text] [Related]
56. Conserved signals around the 5' splice sites in eukaryotic nuclear precursor mRNAs: G-runs are frequent in the introns and C in the exons near both 5' and 3' splice sites.
Nussinov R
J Biomol Struct Dyn; 1989 Apr; 6(5):985-1000. PubMed ID: 2590511
[TBL] [Abstract][Full Text] [Related]
57. A G-to-T transversion at the splice acceptor site of dystrophin exon 14 shows multiple splicing outcomes that are not exemplified by transition mutations.
Ota M; Takeshima Y; Nishida A; Awano H; Lee T; Yagi M; Matsuo M
Genet Test Mol Biomarkers; 2012 Jan; 16(1):3-8. PubMed ID: 21854195
[TBL] [Abstract][Full Text] [Related]
58. Intron sequences and the length of the downstream second exon affect the binding of hnRNP C proteins in an in vitro splicing reaction.
Goswami P; Goldenberg CJ
Nucleic Acids Res; 1988 Jun; 16(11):4995-5011. PubMed ID: 3290845
[TBL] [Abstract][Full Text] [Related]
59. PRO-051, an antisense oligonucleotide for the potential treatment of Duchenne muscular dystrophy.
Hammond SM; Wood MJ
Curr Opin Mol Ther; 2010 Aug; 12(4):478-86. PubMed ID: 20677099
[TBL] [Abstract][Full Text] [Related]
60. Identification and characterization by antisense oligonucleotides of exon and intron sequences required for splicing.
Dominski Z; Kole R
Mol Cell Biol; 1994 Nov; 14(11):7445-54. PubMed ID: 7935459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
